Henderson Land Dev C (HLDCY) 5.8600 $HLDCY JLL Promotes

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Henderson Land Dev C (HLDCY) 5.8600 $HLDCY

JLL Promotes Christian Ulbrich as CEO; To Replace Dyer
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 6:05AM CDT
JLL has announced the appointment of Christian Ulbrich, the president of the company since June, as the new chief executive officer.
JLL: 116.33 (+0.13), CIGI: 42.29 (-0.57)

Kennedy-Wilson Acquires Multifamily Community in California
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:16AM CDT
Kennedy-Wilson Holdings, Inc. (KW) has acquired a 100% ownership stake in a 386-unit multifamily community, for $81 million.
KW: 21.95 (+0.16), CIGI: 42.29 (-0.57)

Jones Lang LaSalle Acquires Asia-Based PDM International
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:16AM CDT
JLL acquired Kuala Lumpur, Malaysia-based interior design consultancy firm PDM International.
JLL: 116.33 (+0.13), CIGI: 42.29 (-0.57)

St. Joe (JOE) Q2 Earnings Surpass Estimates, Revenues Lag
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 9:59AM CDT
The St. Joe Company (JOE) reported second-quarter 2016 net income of $1.8 million or 2 cents per share, surpassing the Zacks Consensus Estimate of a cent per share.
JOE: 18.86 (+0.01)

JLL's Q2 Earnings Miss Estimates, Down Y/Y; Revenues Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:29AM CDT
Jones Lang LaSalle Inc. (JLL) reported second-quarter 2016 adjusted earnings of $1.93 per share, missing the Zacks Consensus Estimate of $1.98.
JLL: 116.33 (+0.13), BATRK: 16.57 (-0.06)

CBRE Group's (CBG) Q2 Earnings Beat, Revenues Rise Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:42PM CDT
Real estate services firm, CBRE Group Inc. (CBG) reported second-quarter 2016 adjusted earnings of 52 cents per share, beating the Zacks Consensus Estimate of 51 cents and ahead of the prior-year tally of 42 cents.
CBG: 29.75 (+0.12), BATRK: 16.57 (-0.06), KW: 21.95 (+0.16)

H Queen's Announces Gallery David Zwirner as Anchor Tenant
PR Newswire - Fri Jun 10, 12:33PM CDT
Henderson Leasing Agency Company Ltd., as a wholly owned subsidiary of Henderson Land Development Company Ltd. (collectively called "Henderson" as well as the leasing and marketing agent of the development H Queen's (HQ), has announced that celebrated art dealer David Zwirner will debut his first gallery in Asia at HQ - the new purpose-built 24-storey gallery and lifestyle tower currently under construction at 80 Queen's Road Central, Hong Kong.

Impulse Dynamics Completes $30 Million Financing Round
PR Newswire - Fri May 13, 10:05AM CDT
Impulse Dynamics, developer of the Optimizer(TM) IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million financing round.

JLL Acquires Bill Goold Realty to Expand Business in Canada
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 1:50PM CST
JLL recently announced the acquisition of Bill Goold Realty, the Vancouver, British Columbia-based commercial realty services firm for multi-family properties.
JLL: 116.33 (+0.13), CBG: 29.75 (+0.12), FSV: 48.93 (-0.35)

The Price Data Tells the Story - Exclusive Reports on Henderson Land Development, Porsche Automobil Holding, PT Astra International, and Crimson Wine Group
ACCESSWIRE - Mon Jan 25, 6:55AM CST
NEW YORK, NY / ACCESSWIRE / January 25, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Henderson Land Development Co Ltd (OTC: HLDCY), Porsche Automobil Holding SE (OTC: POAHY), PT Astra International (OTC: PTAIY), Crimson Wine Group Ltd (OTC: CWGL). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Jones Lang LaSalle (JLL) Acquires Cobertura in Portugal
Zacks Equity Research - Zacks Investment Research - Tue Jan 12, 1:55PM CST
Jones Lang LaSalle Incorporated (JLL) recently acquired Cobertura SA, a popular firm in Portugal's prime residential market.
JLL: 116.33 (+0.13), CBG: 29.75 (+0.12), CIGI: 42.29 (-0.57)

Jones Lang LaSalle Closes Acquisition of Big Red Rooster
Zacks Equity Research - Zacks Investment Research - Mon Jan 11, 2:05PM CST
Jones Lang LaSalle Incorporated (JLL) closed the acquisition of Big Red Rooster, the retail design and brand strategist firm.
RMAX: 41.51 (+0.10), JLL: 116.33 (+0.13), CBG: 29.75 (+0.12)

JLL Buys Real Estate Asset Management Company in Berlin
Zacks Equity Research - Zacks Investment Research - Fri Jan 08, 2:10PM CST
Jones Lang LaSalle Incorporated (JLL) has acquired Berlin-based retail real estate asset management company ACREST.
RMAX: 41.51 (+0.10), JLL: 116.33 (+0.13), CBG: 29.75 (+0.12)

JLL Closes CIB Group Buyout, Boosts Greater Baltimore Reach
Zacks Equity Research - Zacks Investment Research - Tue Jan 05, 3:15PM CST
Jones Lang LaSalle Incorporated (JLL) disclosed the acquisition of CIB, LLC and CIB Management, LLC in a move to expand its footprint in the Greater Baltimore region, MD.
RMAX: 41.51 (+0.10), JLL: 116.33 (+0.13), CBG: 29.75 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading